Michael LaPelusa

9PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsMajor global burdens of diseaseMortality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 15, 2025
Long-Term Efficacy of Pembrolizumab and the Clinical Utility of ctDNA in Locally Advanced dMMR/MSI-H Solid Tumors.

Michael LaPelusa, Wei Qiao, Bryan Iorgulescu

|Dec 16, 2023
Mutational Signature Changes in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal.

Michael LaPelusa, Christopher Cann, Kristen K Ciombor

|Oct 14, 2023
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma.

Betul Gok Yavuz, Saumil Datar, Shadi Chamseddine

|Jul 14, 2023
Systemic Neoadjuvant and Adjuvant Therapies in the Management of Hepatocellular Carcinoma-A Narrative Review.

Shadi Chamseddine, Michael LaPelusa, Ahmed Omar Kaseb

|Jul 27, 2022
Variation in Treatment Patterns of Patients with Early-Onset Gastric Cancer.

Michael LaPelusa, Chan Shen, Erin A Gillaspie

Pageof 2